Podcast Episodes
Back to Search
Podcast: AuToDeCRA, June 2025
Join Professor Ian McInnes from the University of Glasgow, and Professors John Isaacs and Andrew Cope, as they discuss the latest AuToDeCRA study and what this means for rheumatology.
Published on 4 months ago
Webinar Highlights Podcast: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs
Join Professor Herve Bachelez and Professors Iain McInnes and Tim Orchard as they discuss the recent webinar hosted on the IMID Forum: “Advancing Patient Care Through an Interdisciplinary Approach to…
Published on 4 months, 1 week ago
Author Interview: Dr Saqr Alsakarneh, May 2025
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Saqr Alsakarneh, Internal Medicine Resident at University of Missouri–Kansas City in the US, as they discuss ‘Risk of De Nov…
Published on 4 months, 2 weeks ago
Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA
Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast on The Immune-Mediated Inflammatory Disease Foru…
Published on 5 months ago
Discussing RA: MACE, VTE, and malignancy in filgotinib RA and UC patients, and MACE related to JAKis
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, he discusses two papers: risk of …
Published on 5 months, 1 week ago
Highlights Podcast: IL-17 Inhibition: Controlling inflammation and disease progression in SpA
Highlights Podcast: IL-17 Inhibition: Controlling inflammation and disease progression in SpA by The Immune-Mediated Inflammatory Disease Forum
Published on 5 months, 3 weeks ago
Discussing PsA: JAKi Comparative safety & Burden and determinants of multi‑b/tsDMARD failure in PsA
Join Professors Laura Coates and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a discussion on the comparative safety of JAK inhibitors v…
Published on 6 months, 1 week ago
Discussing RA: Pain reduction & choosing second-line DMARDs after unresponsive first-line DMARDs
Join Professors Iain McInnes and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two p…
Published on 6 months, 1 week ago
Author Interview: Professor Phillip Helliwell, March 2025
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Phillip Helliwell, Professor of rheumatology at The University of Leeds in the UK, as they discuss ‘Tight Control and…
Published on 6 months, 2 weeks ago
Author Interview: Professor Phillip Helliwell, 2025
Author Interview: Professor Phillip Helliwell, 2025 by The Immune-Mediated Inflammatory Disease Forum
Published on 6 months, 3 weeks ago